TREM2 MODULATORS

The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases and to pharma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEISSNER, Johannes Wilhelm Georg, BUSCH-PETERSEN, Jakob, WHITLOCK, Gavin, EMMERICH, Juliette
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MEISSNER, Johannes Wilhelm Georg
BUSCH-PETERSEN, Jakob
WHITLOCK, Gavin
EMMERICH, Juliette
description The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases and to pharmaceutical compositions comprising the compounds. La présente invention concerne des composés utiles pour moduler un récepteur de déclenchement exprimé sur les cellules myéloïdes 2 ("TREM2"). L'invention concerne également les composés destinés à être utilisés dans le traitement d'affections liées à la perte de fonction de TREM2, telles que des maladies neurodégénératives, ainsi que des compositions pharmaceutiques comprenant les composés.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024008722A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024008722A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024008722A33</originalsourceid><addsrcrecordid>eNrjZBAICXL1NVLw9XcJ9XEM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgYGFuZGRo7GxsSpAgB9IB51</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREM2 MODULATORS</title><source>esp@cenet</source><creator>MEISSNER, Johannes Wilhelm Georg ; BUSCH-PETERSEN, Jakob ; WHITLOCK, Gavin ; EMMERICH, Juliette</creator><creatorcontrib>MEISSNER, Johannes Wilhelm Georg ; BUSCH-PETERSEN, Jakob ; WHITLOCK, Gavin ; EMMERICH, Juliette</creatorcontrib><description>The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases and to pharmaceutical compositions comprising the compounds. La présente invention concerne des composés utiles pour moduler un récepteur de déclenchement exprimé sur les cellules myéloïdes 2 ("TREM2"). L'invention concerne également les composés destinés à être utilisés dans le traitement d'affections liées à la perte de fonction de TREM2, telles que des maladies neurodégénératives, ainsi que des compositions pharmaceutiques comprenant les composés.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240222&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024008722A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240222&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024008722A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEISSNER, Johannes Wilhelm Georg</creatorcontrib><creatorcontrib>BUSCH-PETERSEN, Jakob</creatorcontrib><creatorcontrib>WHITLOCK, Gavin</creatorcontrib><creatorcontrib>EMMERICH, Juliette</creatorcontrib><title>TREM2 MODULATORS</title><description>The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases and to pharmaceutical compositions comprising the compounds. La présente invention concerne des composés utiles pour moduler un récepteur de déclenchement exprimé sur les cellules myéloïdes 2 ("TREM2"). L'invention concerne également les composés destinés à être utilisés dans le traitement d'affections liées à la perte de fonction de TREM2, telles que des maladies neurodégénératives, ainsi que des compositions pharmaceutiques comprenant les composés.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAICXL1NVLw9XcJ9XEM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgYGFuZGRo7GxsSpAgB9IB51</recordid><startdate>20240222</startdate><enddate>20240222</enddate><creator>MEISSNER, Johannes Wilhelm Georg</creator><creator>BUSCH-PETERSEN, Jakob</creator><creator>WHITLOCK, Gavin</creator><creator>EMMERICH, Juliette</creator><scope>EVB</scope></search><sort><creationdate>20240222</creationdate><title>TREM2 MODULATORS</title><author>MEISSNER, Johannes Wilhelm Georg ; BUSCH-PETERSEN, Jakob ; WHITLOCK, Gavin ; EMMERICH, Juliette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024008722A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MEISSNER, Johannes Wilhelm Georg</creatorcontrib><creatorcontrib>BUSCH-PETERSEN, Jakob</creatorcontrib><creatorcontrib>WHITLOCK, Gavin</creatorcontrib><creatorcontrib>EMMERICH, Juliette</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEISSNER, Johannes Wilhelm Georg</au><au>BUSCH-PETERSEN, Jakob</au><au>WHITLOCK, Gavin</au><au>EMMERICH, Juliette</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREM2 MODULATORS</title><date>2024-02-22</date><risdate>2024</risdate><abstract>The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases and to pharmaceutical compositions comprising the compounds. La présente invention concerne des composés utiles pour moduler un récepteur de déclenchement exprimé sur les cellules myéloïdes 2 ("TREM2"). L'invention concerne également les composés destinés à être utilisés dans le traitement d'affections liées à la perte de fonction de TREM2, telles que des maladies neurodégénératives, ainsi que des compositions pharmaceutiques comprenant les composés.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2024008722A3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TREM2 MODULATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A58%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEISSNER,%20Johannes%20Wilhelm%20Georg&rft.date=2024-02-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024008722A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true